We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

3 hedge funds and large institutions have $815K invested in BioCardia, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $781K → $815K (+$34K)

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.92K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$734K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$79K – – –
UBS Group
3
UBS Group
Switzerland
$2K +$1.92K +1,354 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
– -$17K -12,188 Closed

BCDAW Hedge Fund Activity: Q2 2021 in Review

3 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q2 2021, worth a combined $815K — up 4.4% from $781K a quarter earlier.

Fund positioning in BCDAW was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.92K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $17K sold.

  • 3 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $815K of BioCardia, Inc. Warrant stock for Q2 2021, up 4.4% quarter-over-quarter.
  • 1 fund opened new BioCardia, Inc. Warrant positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest BioCardia, Inc. Warrant buyer in Q2 2021 was UBS Group, an estimated $1.92K added.
  • The largest BioCardia, Inc. Warrant seller in Q2 2021 was Susquehanna International Group, an estimated $17K sold.

Based on aggregated 13F filings for Q2 2021.